Sinus Dilation Devices Market Worth 2.78 Billion USD by 2023

PUNE, India, June 13, 2018 /PRNewswire/ --

According to a new market research report "Sinus Dilation Devices Market by Product (Balloon Dilation, Stents, Endoscope (Rhinoscopy, Sinoscopy), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric), Patient Care Setting (ENT, Clinic, Hospitals, ASC) - Global Forecast to 2023", published by MarketsandMarkets™, the global market is expected to reach USD 2.78 Billion by 2023 from USD 1.80 Billion in 2018, at a CAGR of 9.1%.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Browse 62 market data Tables and 32 Figures spread through 116 Pages and in-depth TOC on "Sinus Dilation Devices Market"

https://www.marketsandmarkets.com/Market-Reports/sinus-dilation-device-market-64349810.html

Early buyers will receive 10% customization on this report 

The growth of the market can be attributed to the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries.

Balloon sinus dilation devices segment is expected to dominate the market in 2018 

Based on product, the Sinus Dilation Devices Market is segmented into balloon sinus dilation devices, endoscopes, sinus stents/implants, and handheld instruments. The balloon Sinus Dilation Devices Market is further classified as standalone and hybrid according to the type of procedure. In 2018, balloon sinus dilation devices are expected to account for the largest share of the global Sinus Dilation Devices Market. This large share can be attributed to the rising prevalence of chronic sinusitis, increasing preference for minimally invasive surgical procedures, and the increasing focus of market players on launching advanced balloon sinus dilation devices.

Based on patient care setting, the ENT clinics/in office segment is projected to grow at the highest CAGR during the forecast period 

Based on patient care setting, the Sinus Dilation Devices Market is segmented into hospitals, ambulatory surgical centers, and ENT clinics/in office. The ENT clinics/in office segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to increasing number of treatable patients in ENT clinics, faster recovery time, cost-effectiveness, and growing preference for minimally invasive techniques.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=64349810

North America is expected to dominate the Sinus Dilation Devices Market in 2018 

In 2018, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to rapidly increasing geriatric population, rising prevalence of chronic sinusitis, higher adoption of new technologies among ENT surgeons and otolaryngologists, favorable reimbursement scenario, and the presence of major players in this region.

The Sinus Dilation Devices Market includes various small and large players. Key players in this market include Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China), and Creganna Medical (Ireland).

Know more about the Sinus Dilation Devices Market: 

https://www.marketsandmarkets.com/Market-Reports/sinus-dilation-device-market-64349810.html

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Blog: http://www.marketsandmarketsblog.com/market-reports/healthcare/medical-devices
Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets  

SOURCE MarketsandMarkets